336 related articles for article (PubMed ID: 15166270)
21. Pathways for aberrant angiogenesis in pancreatic cancer.
Korc M
Mol Cancer; 2003 Jan; 2():8. PubMed ID: 12556241
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines.
Fukasawa M; Korc M
Clin Cancer Res; 2004 May; 10(10):3327-32. PubMed ID: 15161686
[TBL] [Abstract][Full Text] [Related]
23. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis.
Maruyama Y; Ono M; Kawahara A; Yokoyama T; Basaki Y; Kage M; Aoyagi S; Kinoshita H; Kuwano M
Cancer Res; 2006 Jun; 66(12):6233-42. PubMed ID: 16778198
[TBL] [Abstract][Full Text] [Related]
24. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters.
Bolat F; Kayaselcuk F; Nursal TZ; Yagmurdur MC; Bal N; Demirhan B
J Exp Clin Cancer Res; 2006 Sep; 25(3):365-72. PubMed ID: 17167977
[TBL] [Abstract][Full Text] [Related]
25. High neuropilin 1 expression was associated with angiogenesis and poor overall survival in resected pancreatic ductal adenocarcinoma.
Ben Q; Zheng J; Fei J; An W; Li P; Li Z; Yuan Y
Pancreas; 2014 Jul; 43(5):744-9. PubMed ID: 24632553
[TBL] [Abstract][Full Text] [Related]
26. Markers of tumour angiogenesis and tumour cells in bone marrow in gastric cancer patients.
Gretschel S; Astrosini Ch; Vieth M; Jöns T; Tomov T; Höcker M; Schlag PM; Kemmner W
Eur J Surg Oncol; 2008 Jun; 34(6):642-7. PubMed ID: 18023552
[TBL] [Abstract][Full Text] [Related]
27. A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis.
Zhou R; Curry JM; Roy LD; Grover P; Haider J; Moore LJ; Wu ST; Kamesh A; Yazdanifar M; Ahrens WA; Leung T; Mukherjee P
Oncogene; 2016 Oct; 35(43):5608-5618. PubMed ID: 26804176
[TBL] [Abstract][Full Text] [Related]
28. Nestin as a novel therapeutic target for pancreatic cancer via tumor angiogenesis.
Yamahatsu K; Matsuda Y; Ishiwata T; Uchida E; Naito Z
Int J Oncol; 2012 May; 40(5):1345-57. PubMed ID: 22246533
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of VEGF in human pancreatic ductal adenocarcinoma.
Lim YJ; Lee JK; Park CK; Song SY; Jang WY; Ha HY; Park DI; Lee KT; Paik SW; Yoo BC; Rhee JC
Korean J Intern Med; 2004 Mar; 19(1):10-4. PubMed ID: 15053037
[TBL] [Abstract][Full Text] [Related]
30. Does contrast-enhanced ultrasound reveal tumor angiogenesis in pancreatic ductal carcinoma? A prospective study.
Nishida M; Koito K; Hirokawa N; Hori M; Satoh T; Hareyama M
Ultrasound Med Biol; 2009 Feb; 35(2):175-85. PubMed ID: 18845377
[TBL] [Abstract][Full Text] [Related]
31. Microvascular density in chronic pancreatitis and pancreatic ductal adenocarcinoma.
Rzepko R; Jaśkiewicz K; Klimkowska M; Nałecz A; Izycka-Swieszewska E
Folia Histochem Cytobiol; 2003; 41(4):237-9. PubMed ID: 14677765
[TBL] [Abstract][Full Text] [Related]
32. Cancer-stellate cell interactions perpetuate the hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma.
Erkan M; Reiser-Erkan C; Michalski CW; Deucker S; Sauliunaite D; Streit S; Esposito I; Friess H; Kleeff J
Neoplasia; 2009 May; 11(5):497-508. PubMed ID: 19412434
[TBL] [Abstract][Full Text] [Related]
33. [Coexpression of VEGF and bFGF is associated with increased vascular density in head and neck carcinomas].
Riedel F; Götte K; Schwalb J; Bergler W; Hörmann K
Laryngorhinootologie; 2000 Dec; 79(12):730-5. PubMed ID: 11199455
[TBL] [Abstract][Full Text] [Related]
34. Neovascularization in pancreatic ductal adenocarcinoma: Microvessel count analysis, comparison with non-cancerous regions and other types of carcinomas.
Ueda T; Oda T; Kinoshita T; Konishi M; Nakahashi C; Takahashi S; Hasebe T; Fukao K; Ochiai A
Oncol Rep; 2002; 9(2):239-45. PubMed ID: 11836587
[TBL] [Abstract][Full Text] [Related]
35. MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas.
Saitou M; Goto M; Horinouchi M; Tamada S; Nagata K; Hamada T; Osako M; Takao S; Batra SK; Aikou T; Imai K; Yonezawa S
J Clin Pathol; 2005 Aug; 58(8):845-52. PubMed ID: 16049287
[TBL] [Abstract][Full Text] [Related]
36. Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ.
Wülfing P; Kersting C; Buerger H; Mattsson B; Mesters R; Gustmann C; Hinrichs B; Tio J; Böcker W; Kiesel L
Br J Cancer; 2005 May; 92(9):1720-8. PubMed ID: 15841074
[TBL] [Abstract][Full Text] [Related]
37. Morphometric microvascular characteristics in the prognosis of pancreatic and ampullary carcinoma.
Giannopoulos G; Kavantzas N; Parasi A; Tiniakos D; Peros G; Tzanakis N; Patsouris E; Pavlakis K
Pancreas; 2007 Jul; 35(1):47-52. PubMed ID: 17575545
[TBL] [Abstract][Full Text] [Related]
38. Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance.
Wang L; Xiong L; Wu Z; Miao X; Liu Z; Li D; Zou Q; Yang Z
World J Surg Oncol; 2018 Jan; 16(1):11. PubMed ID: 29347944
[TBL] [Abstract][Full Text] [Related]
39. Angiogenesis index CD105 (endoglin)/CD31 (PECAM-1) as a predictive factor for invasion and proliferation in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
Tachezy M; Reichelt U; Melenberg T; Gebauer F; Izbicki JR; Kaifi JT
Histol Histopathol; 2010 Oct; 25(10):1239-46. PubMed ID: 20712008
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
